{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:08:55Z","timestamp":1791079735516,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":5015,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1093\/annonc\/mdj135","type":"journal-article","created":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T20:39:38Z","timestamp":1137011978000},"page":"668-675","source":"Crossref","is-referenced-by-count":142,"title":["Polymorphisms in DNA repair genes modulate survival in cisplatin\/gemcitabine-treated non-small-cell lung cancer patients"],"prefix":"10.1016","volume":"17","author":[{"given":"R.","family":"de las Pe\u00f1as","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sanchez-Ronco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Alberola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Taron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Garcia-Carbonero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Massuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Queralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Botia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Garcia-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Isla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Santarpia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cecere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdj135_bb0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdj135_bb0015","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1200\/JCO.2005.04.177","article-title":"Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data","volume":"23","author":"Hoang","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj135_bb0020","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/carcin\/22.9.1437","article-title":"XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects","volume":"22","author":"Matullo","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdj135_bb0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/carcin\/23.2.295","article-title":"Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD\/ERCC2 genotypes","volume":"23","author":"Qiao","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdj135_bb0030","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1093\/carcin\/bgh264","article-title":"Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer","volume":"25","author":"Popanda","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdj135_bb0035","first-page":"5457","article-title":"Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD","volume":"62","author":"Aloyz","year":"2002","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdj135_bb0040","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients","volume":"61","author":"Spitz","year":"2001","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdj135_bb0045","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/carcin\/bgh344","article-title":"Polymorphisms in XPD and TP53 and mutation in human lung cancer","volume":"26","author":"Mechanic","year":"2005","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdj135_bb0050","first-page":"1377","article-title":"Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer","volume":"62","author":"Zhou","year":"2002","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdj135_bb0055","first-page":"359","article-title":"Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking","volume":"12","author":"Zhou","year":"2003","journal-title":"and lung cancer risk. Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdj135_bb0060","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/jnci\/92.21.1764","article-title":"Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study","volume":"92","author":"Wei","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdj135_bb0065","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/jnci\/94.14.1091","article-title":"An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer","volume":"94","author":"Bosken","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdj135_bb0070","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy","volume":"22","author":"Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdj135_bb0075","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/carcin\/21.11.1977","article-title":"Identification of single nucleotide polymorphisms in human DNA repair genes","volume":"21","author":"Ford","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdj135_bb0080","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdh319","article-title":"Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer","volume":"15","author":"Isla","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdj135_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2003.11.019","article-title":"Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy","volume":"44","author":"Ryu","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdj135_bb0090","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/sj.bjc.6601975","article-title":"A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU\/oxaliplatin combination chemotherapy in refractory colorectal cancer","volume":"91","author":"Stoehlmacher","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdj135_bb0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/carcin\/bgh002","article-title":"Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study","volume":"25","author":"Han","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdj135_bb0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lungcan.2004.07.043","article-title":"Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance","volume":"47","author":"Bepler","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1093\/annonc\/mdj135_bb0105","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/mutage\/geg008","article-title":"53 polymorphisms and lung cancer risk: a systematic review and meta-analysis","volume":"18","author":"Matakidou","year":"2003","journal-title":"Mutagenesis"},{"key":"10.1093\/annonc\/mdj135_bb0110","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1038\/sj.onc.1207428","article-title":"Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo","volume":"23","author":"Sullivan","year":"2004","journal-title":"Oncogene"},{"key":"10.1093\/annonc\/mdj135_bb0115","doi-asserted-by":"crossref","first-page":"4348","DOI":"10.1158\/1078-0432.CCR-04-1547","article-title":"Evaluation of the combined effect of p53 codon 72 polymorphism and hotspot mutations in response to anticancer drugs","volume":"11","author":"Vikhanskaya","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdj135_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/carcin\/bgh008","article-title":"Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer","volume":"25","author":"Campa","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1093\/annonc\/mdj135_bb0125","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1158\/0008-5472.CAN-03-3137","article-title":"A functional polymorphism in the EGF gene is found with increased frequency in glioblastoma multiforme patients and is associated with more aggressive disease","volume":"64","author":"Bhowmick","year":"2004","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdj135_bb0130","first-page":"397","article-title":"Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study","volume":"10","author":"Shen","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1093\/annonc\/mdj135_bb0135","first-page":"4519","article-title":"Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors","volume":"62","author":"Paz","year":"2002","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdj135_bb0140","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1158\/1078-0432.CCR-04-0247","article-title":"Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy","volume":"10","author":"Zhou","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1093\/annonc\/mdj135_bb0145","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/(SICI)1097-0215(20000320)89:2<160::AID-IJC10>3.0.CO;2-J","article-title":"DNA-adduct levels as a predictor of outcome for NSCLC patients receiving daily cisplatin and radiotherapy","volume":"89","author":"van de Vaart","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1093\/annonc\/mdj135_bb0150","first-page":"4103","article-title":"Reduced DNA repair capacity in lung cancer patients","volume":"56","author":"Wei","year":"1996","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdj135_bb0155","first-page":"4760","article-title":"Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy","volume":"55","author":"Zeng-Rong","year":"1995","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdj135_bb0160","first-page":"6221","article-title":"BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis","volume":"63","author":"Quinn","year":"2003","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdj135_bb0165","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1093\/hmg\/ddh260","article-title":"BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer","volume":"13","author":"Taron","year":"2004","journal-title":"Hum Mol Genet"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419575627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419575627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/17\/4\/668\/13134272\/mdj135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T03:47:52Z","timestamp":1624420072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419575627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0923753419575627"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdj135","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}